Shed presents GLP-1 weight-care plans alongside vitality and wellness offerings. Its site describes compounded semaglutide and tirzepatide, nutrition resources, and a shot-tracking app.
The broader menu also includes microdose programs. Those should be assessed separately from standard obesity treatment because the intended goals and evidence may differ.
Offer highlights
- Compounded GLP-1 treatments listed
- Shot-tracking app resources described
- Lower-dose and wellness menu presented
Ask before paying
- What commitment produces the starting rate?
- What dose and preparation is supplied?
- Which lower-dose claims have direct clinical evidence?
Products, pricing & billing
The fresh homepage advertised compounded semaglutide as low as $159 per month and compounded tirzepatide starting as low as $239. Confirm the plan term, total charge, quantity, and renewal rate attached to those figures.
A rate described as “as low as” can depend on a selected commitment or offer. Ask whether the medicine, supplies, clinical care, and delivery are included in the final quote.
Care and follow-up
Shed describes resources for nutrition, movement, and mindset, along with tracking support. Ask which resources involve a clinician or coach and which are self-guided materials.
Its lower-dose marketing describes several potential wellness effects. We do not treat those claims as established longevity outcomes. A clinician should explain what is known, what is uncertain, and how treatment will be monitored.
Our take
Shed is useful for comparing a GLP-1 plan with wellness resources. The clearest evaluation keeps the standard weight-care offer separate from its microdose marketing and uses the full invoice rather than an isolated starting rate.
Put the offer in context
Read the GLP-1 program comparison and complete cost guide to compare membership, medication, and recurring charges. The branded and compounded treatment guide explains the product distinctions.
Our CoreAge Rx review describes its advertised medicine-inclusive monthly offer and refund deadlines.
Sources & offer details
Public information retrieved on October 1, 2026. Provider statements describe the advertised offer; they do not independently establish treatment outcomes.